Funded Tech Companies
AvenCell
Wondering who provided funding to AvenCell? Blackstone, Piper Heartland and NYBC Ventures joined the equity holders in this healthcare services company.
Company Overview
Company Name
AvenCell
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
500 Forge Road
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Company Background Information
Overview
AvenCell Therapeutics, Inc. was recently launched by Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics, Inc. and incorporated the clinical-stage biopharmaceutical company GEMoaB GmbH, now named AvenCell Europe GmbH. Our mission is to overcome the limitations of current CAR-T cell therapies by introducing the next generation of immunotherapies to patients, everywhere.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/22/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Schiermeier
Chief Financial Officer
Babar Ghias
Chief Medical Officer
Tapan Maniar
Chief Scientific Officer
Armin Ehninger
Chief Technical Officer
Marc Cartellieri
Vice President
Manfred Klevesath
VP - Finance
Andrea Kistner
VP - Human Resources
Jill Rogers
VP - Operations
Susan Buttler
VP - Operations
Markus Orchowski
VP - R & D
Reynald Lescarbeau
Company Investors
- Blackstone
- Piper Heartland
- NYBC Ventures
- F-Prime Capital (Nihal Sinha)
- Novo Holdings (Michael Bauer)
- Eight Roads
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs